Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 30, 2009, 2:10PM ET - U.S. Markets close in 1 hour and 50 minutes. Dow  0.10% Nasdaq  0.18%

Columbia Laboratories Inc. (CBRX)

At 1:41PM ET: 1.02   0.01 (0.97%)

MORE ON CBRX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Industry: Drug Delivery Get Industry for:
CBRX SECTOR / INDUSTRY MEMBERSHIP Sector: Healthcare Industry: Drug Delivery INTRADAY PERFORMANCE SUMMARY Name Ticker Change Columbia Laboratories Inc. CBRX 0.97% Drug Delivery ^YHOh786 0.65% View Drug Delivery Industry Center DRUG DELIVERY INDUSTRY NEWS • Jackson Hewitt Tax Services, pSivida: Biggest Price Decliners (JTX, PSDV) Thu 2:31 PM - at The Wall Street Journal Online • NovaDel Announces Listing on OTC Bulletin Board Thu 8:00 AM - Business Wire • Doral Financial, pSivida: Biggest Price Gainers (DRL, PSDV) Wed 4:37 PM - at The Wall Street Journal Online • Psivida bullish over eye-disease drug trial Wed 3:05 PM - at bizjournals.com • Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010 Wed 3:00 PM - PR Newswire More Industry News... TOP DRUG DELIVERY COMPANIES BY MARKET CAP Company Symbol Price Change Market Cap P/E Hospira Inc. HSP 51.00 0.20% 8.27B 20.06 Elan Corp. plc ELN 6.39 1.69% 3.14B 60.28 Biovail Corporation BVF 13.85 0.86% 2.19B 9.80 Alkermes, Inc. ALKS 9.46 1.05% 896.48M 11.24 Nektar Therapeutics NKTR 8.9825 0.14% 837.14M N/A Columbia Laboratories Inc. CBRX 1.02 0.97% 66.94M N/A Showing 1 - 5 of 21 - View All More Top Companies: by Performance, by Valuation, by Growth, more... CBRX VS. INDUSTRY LEADERS Statistic Industry Leader CBRX CBRX Rank Market Capitalization HSP 8.27B 66.94M 13 / 21 P/E Ratio (ttm) ELN 60.28 N/A N/A PEG Ratio (ttm, 5 yr expected) BVF 1.43 N/A N/A Revenue Growth (Qtrly YoY) PPCO 362.50% -28.90% 13 / 21 EPS Growth (Qtrly YoY) HSP 40.20% N/A N/A Long-Term Growth Rate (5 yr) ALKS 19.5% N/A N/A Return on Equity (ttm) ELN 62.31% N/A N/A Long-Term Debt/Equity (mrq) N/A Dividend Yield (annual) BVF 2.60% N/A N/A View Leaders & Laggards MORE ON DRUG DELIVERY • Industry Summary • News • Leaders & Laggards • Company List • Industry Calendar RELATED INDUSTRIES • Biotechnology • Diagnostic Substances • Drug Manufacturers - Major • Drug Manufacturers - Other • Drug Related Products • Drugs - Generic Top Performing Industries | Complete Industry List
Add to Portfolio     Set Alert     Email to a Friend Get Industry for Another Symbol: Symbol Lookup • Research Reports Screener • Industry Center